Search - tctmd.com

Displaying 1 - 20 of 37

Sort: Relevancy | Date

News Daily News

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Michael O'Riordan

July 14, 2025

News Opinion Editor's Corner

The Biggest News of 2023: TCTMD’s Top 10

Shelley Wood

January 01, 2024

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Conference News ESC 2023

COP-AF: Colchicine Doesn’t Cut Post-Op AF or Myocardial Injury

Michael O'Riordan

August 25, 2023

News Daily News

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

Todd Neale

August 08, 2023

News Conference News ADA 2023

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Michael O'Riordan

June 28, 2023

News Daily News

FDA Approves Colchicine for Decreasing CV Events

Caitlin E. Cox

June 20, 2023

News Conference News ACC 2023

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Caitlin E. Cox

March 14, 2023

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

News Conference News ESC 2022

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

Shelley Wood

August 27, 2022

News Daily News

Acute MI, Stroke Risks Rise in the Months After Gout Flares

Todd Neale

August 02, 2022

News Opinion CV Team Dispatch

May 2022 News Roundup

L.A. McKeown

May 01, 2022

News Daily News

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Michael O'Riordan

August 26, 2021

News Daily News

Meta-analysis Affirms Colchicine’s Myriad CV Benefits

Caitlin E. Cox

April 12, 2021

News Daily News

Colchicine in the Crosshairs for Its High US Cost

Caitlin E. Cox

December 01, 2020

News Conference News ESC 2020

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

Caitlin E. Cox

August 31, 2020

News Daily News

Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data

Yael L. Maxwell

July 07, 2020

News Conference News ACC 2020

Colchicine Cost-effective in Canada, and Even in the US: COLCOT

Caitlin E. Cox

March 28, 2020

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

News Conference News AHA 2019

No Benefit of Colchicine in All-Comers PCI

Shelley Wood

November 17, 2019

Advertisement

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

The Biggest News of 2023: TCTMD’s Top 10

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

COP-AF: Colchicine Doesn’t Cut Post-Op AF or Myocardial Injury

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

FDA Approves Colchicine for Decreasing CV Events

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

Acute MI, Stroke Risks Rise in the Months After Gout Flares

May 2022 News Roundup

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Meta-analysis Affirms Colchicine’s Myriad CV Benefits

Colchicine in the Crosshairs for Its High US Cost

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data

Colchicine Cost-effective in Canada, and Even in the US: COLCOT

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

No Benefit of Colchicine in All-Comers PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content